Diabetes Meds Linked to Heart Failure

Drug Industry Daily
A A
Following a safety review, the FDA has decided to add warnings to the labels of Type 2 diabetes drugs containing saxagliptin and alogliptin due to the increased risk of heart failure in patients with kidney or heart disease.

To View This Article:

Login

Subscribe To Drug Industry Daily